Prevalence of Anxiety and Depression Among Hemodialysis Patients at Sohag University Hospital

March 25, 2026 updated by: Norhan Hussien, Sohag University

The aim of this study is to determine the prevalence of anxiety and depression among hemodialysis patients attending Sohag University Hospital and to identify the sociodemographic and clinical factors associated with these psychological disorders.

The study is a descriptive cross-sectional study conducted on patients undergoing maintenance hemodialysis at the Hemodialysis Unit, Sohag University Hospital.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

160

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

CKD on dialysis patients at Sohag University

Description

Inclusion Criteria:

  • Patients diagnosed with end-stage renal disease (ESRD) and maintained on regular hemodialysis for at least 3 months.
  • Patients aged more than 18 years old.
  • Patients receiving hemodialysis three sessions per week, each lasting 3-4 hours.
  • Patients who can communicate effectively and are able to complete the required questionnaires.
  • Patients able to provide informed consent.

Exclusion Criteria:

  • Patients suffering from major visual or hearing impairments.
  • Patients with a known psychiatric disorder diagnosed prior to initiation of hemodialysis.
  • Patients receiving psychiatric medications or active psychotherapy.
  • Patients with severe cerebrovascular diseases.
  • Patients with chronic liver diseases, lung diseases or malignancies that can add additional psychological burden.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
CKD on dialysis patients
Other: No Interventions
No interventions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Questionnaire for the Prevalence of Anxiety and Depression Among Hemodialysis Patients at Sohag University Hospital
Time Frame: From enrollment to the end of treatment at 8 weeks
From enrollment to the end of treatment at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

February 28, 2026

First Submitted That Met QC Criteria

March 25, 2026

First Posted (Actual)

March 31, 2026

Study Record Updates

Last Update Posted (Actual)

March 31, 2026

Last Update Submitted That Met QC Criteria

March 25, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Soh-Med-26-2-7MS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe